Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer

Raquibul Hannan,Michael Christensen,Hans Hammers,Alana Christie, Brendan Paulman, Dandan Lin,Aurelie Garant,Waddah Arafat,Kevin Courtney,Isaac Bowman, Suzanne Cole,David Sher,Chul Ahn,Hak Choy,Robert Timmerman,James Brugarolas

European Urology Oncology（2022）

引用 18|浏览16

暂无评分

摘要

Stereotactic ablative radiation (SAbR) extended the duration of ongoing systemic therapy for patients with oligoprogressive metastatic renal cell carcinoma (mRCC) without undermining quality of life. These data support the evaluation of SAbR as the therapeutic modality of choice for oligoprogressive mRCC in a prospective randomized clinical trial.

查看译文

关键词

Oligometastasis,Oligoprogression,Renal cell carcinoma,Stereotactic ablative radiation,Stereotactic body radiation therapy,Stereotactic radiation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要